Stock Attack -- A Complete Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Attack -- A Complete Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Judy who wrote (14692)	8/18/1998 7:18:00 PM
From: Nancy	Read Replies (1) of 42787

judy, wla's problem is the same old one - its rezulin can cause liver damage if not closely monitored by doctors - just like any other important drugs if not administered properly, you always have some problems. from earnings growth perspective, wla has the highest growth rate. from pipeline growth & overall management perspective, pfe still the king. big pharmas usually trade with the market. if wla drops back, would use the opp to add.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next